AVXL - Company ID 0001314052
The table below shows ANAVEX LIFE SCIENCES CORP.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $118.33M | $127.42M | $131.75M | $101.16M | $115.77M | $120.78M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| - |
| - |
| - |
| Property, plant & equipment | - | - | - | - | - | - |
| Goodwill | - | - | - | - | - | - |
| Total assets | $120.14M | $128.77M | $132.99M | $102.43M | $117.14M | $124.04M |
| Accounts payable | $3.66M | $2.52M | $2.64M | $6.74M | $7.00M | $4.57M |
| Total current liabilities | - | - | - | - | - | - |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $7.69M | $7.06M | $6.37M | $11.47M | $17.38M | $13.13M |
| Retained earnings | -$385.64M | -$393.47M | -$388.13M | -$372.62M | -$359.38M | -$348.18M |
| Total equity | $112.45M | $121.71M | $126.62M | $90.96M | $99.76M | $110.92M |